SEC Form 4 · accession 0001104659-18-006256
OCULAR THERAPEUTIX, INC · OCUL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amarpreet Sawhney
Officer — Exec Chairman of the Board · Director
Period of report
Jan 31, 2018
Accepted (ET)
Feb 2, 2018 · 4:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001393434
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $5.47 | Jan 31, 2018 | A | 130,000 | A | — | Jan 30, 2028 | Common Stock | 130,000 | 130,000 | D |
Explanation of responses
- F1Vests over four years, vesting 1/48 monthly beginning on the one-month anniversary of the date of grant.